Coleman Jon's Form 4 filing
Dexcom Inc (DXCM) · filed Jun 5, 2026
- Accession no.
- 0001093557-26-000127
- Filed
- Jun 5, 2026
- Trade date
- Jun 3-4, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions. Open-market sales total $722.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Coleman JonCIK 0001442689 | Officer (EVP, Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 3, 2026 | Common Stock | SSaleDisposed | −4,912 | $73.00 | −$358,576 | 100,361 | Direct | |
| Jun 4, 2026 | Common Stock | SSaleDisposed | −4,911 | $74.13 | −$364,052.43 | 95,450 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.